Total Payments
$5,491
2024 Payments
$1,001
Companies
31
Transactions
250
Medicare Patients
7,548
Medicare Billing
$913,090
Payment Breakdown by Category
Food & Beverage$4,892 (89.1%)
Travel$379.64 (6.9%)
Education$213.80 (3.9%)
Other$5.49 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,892 | 239 | 89.1% |
| Travel and Lodging | $379.64 | 4 | 6.9% |
| Education | $213.80 | 6 | 3.9% |
| Entertainment | $5.49 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $714.08 | 29 | $0 (2024) |
| Medtronic Vascular, Inc. | $582.36 | 14 | $0 (2020) |
| Medtronic, Inc. | $511.69 | 18 | $0 (2024) |
| PFIZER INC. | $497.18 | 25 | $0 (2024) |
| Abbott Laboratories | $497.15 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $395.89 | 24 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $357.82 | 23 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $289.08 | 16 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $248.85 | 19 | $0 (2024) |
| Astellas Pharma US Inc | $214.65 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,001 | 43 | Abbott Laboratories ($209.53) |
| 2023 | $637.02 | 28 | PFIZER INC. ($102.06) |
| 2022 | $660.82 | 25 | Medtronic, Inc. ($333.52) |
| 2021 | $241.55 | 12 | Abbott Laboratories ($129.79) |
| 2020 | $266.29 | 15 | Boston Scientific Corporation ($88.03) |
| 2019 | $953.24 | 52 | Astellas Pharma US Inc ($214.65) |
| 2018 | $1,010 | 37 | Medtronic Vascular, Inc. ($489.01) |
| 2017 | $721.46 | 38 | BOSTON SCIENTIFIC CORPORATION ($283.80) |
All Payment Transactions
250 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/18/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.42 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/26/2024 | Medtronic, Inc. | PERCEPTA QUAD CRT-P MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Cardiac Resynchronization Therapy - CRT | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: DIABETES | ||||||
| 08/21/2024 | Medtronic, Inc. | AZURE XT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Pacemakers | ||||||
| 08/14/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.19 | General |
| Category: Cardiovascular | ||||||
| 07/24/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/19/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $164.90 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.81 | General |
| Category: DIABETES | ||||||
| 07/11/2024 | Medtronic, Inc. | COBALT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 06/24/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.83 | General |
| Category: Cardiovascular | ||||||
| 06/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/12/2024 | Smith+Nephew, Inc. | Bone Anchors with Arthroscopic Delivery System (Device) | Food and Beverage | In-kind items and services | $34.61 | General |
| Category: Extremities & Limb Restoration | ||||||
| 06/06/2024 | BIOTRONIK INC. | Acticor 7 VR-T DX (Device) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/29/2024 | Azurity Pharmaceuticals, Inc. | EDARBYCLOR (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/20/2024 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 2,011 | 3,384 | $828,384 | $200,083 |
| 2022 | 32 | 1,968 | 3,535 | $899,774 | $254,469 |
| 2021 | 35 | 1,929 | 3,531 | $745,910 | $254,888 |
| 2020 | 28 | 1,640 | 2,966 | $589,056 | $203,649 |
Total Patients
7,548
Total Services
13,416
Medicare Billing
$913,090
Procedure Codes
128
All Medicare Procedures & Services
128 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 390 | 634 | $151,031 | $55,939 | 37.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 147 | 254 | $76,002 | $14,495 | 19.1% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 239 | 518 | $38,850 | $13,350 | 34.4% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 17 | 17 | $67,779 | $12,046 | 17.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 94 | 94 | $29,096 | $11,200 | 38.5% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 33 | 33 | $65,481 | $10,821 | 16.5% |
| 93653 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | Facility | 2023 | 16 | 17 | $58,192 | $10,611 | 18.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 49 | 52 | $37,906 | $7,685 | 20.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 49 | 55 | $18,443 | $7,368 | 40.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 166 | 344 | $37,548 | $7,111 | 18.9% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 40 | 69 | $27,416 | $5,560 | 20.3% |
| 33225 | Insertion of left lower heart electrode for pacemaker or defibrillator | Facility | 2023 | 15 | 15 | $26,609 | $5,203 | 19.6% |
| 93650 | Destruction of heart conduction tissue to create heart block | Facility | 2023 | 11 | 11 | $22,713 | $4,580 | 20.2% |
| 93281 | Programming of multiple lead pacemaker system | Office | 2023 | 37 | 66 | $20,908 | $4,282 | 20.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 42 | 66 | $12,289 | $3,936 | 32.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 36 | 37 | $13,033 | $3,565 | 27.4% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 63 | 148 | $26,788 | $3,525 | 13.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 197 | 315 | $16,188 | $3,174 | 19.6% |
| 93609 | Insertion of tube in upper and/or lower heart chambers to record and identify origin of abnormal heart rhythm | Facility | 2023 | 11 | 11 | $15,809 | $2,305 | 14.6% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 17 | 29 | $10,690 | $2,300 | 21.5% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2023 | 51 | 65 | $13,184 | $2,297 | 17.4% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 23 | 112 | $10,667 | $1,981 | 18.6% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 52 | 70 | $6,667 | $1,415 | 21.2% |
| 93285 | Programming of cardiac rhythm monitor system | Office | 2023 | 19 | 27 | $6,151 | $1,321 | 21.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 20 | $3,369 | $1,146 | 34.0% |
About Dr. Ryan Williams, M.D
Dr. Ryan Williams, M.D is a Internal Medicine healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1760664072.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Williams, M.D has received a total of $5,491 in payments from pharmaceutical and medical device companies, with $1,001 received in 2024. These payments were reported across 250 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($4,892).
As a Medicare-enrolled provider, Williams has provided services to 7,548 Medicare beneficiaries, totaling 13,416 services with total Medicare billing of $913,090. Data is available for 4 years (2020–2023), covering 128 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Clinical Cardiac Electrophysiology
- Location Dallas, TX
- Active Since 11/28/2007
- Last Updated 04/12/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1760664072
Products in Payments
- ELIQUIS (Drug) $665.16
- Micra (Device) $464.57
- ENTRESTO (Drug) $347.66
- LifeVest (Device) $289.08
- MULTAQ (Drug) $273.17
- XARELTO (Drug) $177.90
- GALLANT (Device) $164.90
- PRADAXA (Drug) $141.14
- VERQUVO (Drug) $125.22
- X4 CRTD (Device) $112.83
- Quadra Assura CRT Defibrillator (Device) $110.01
- INGEVITY (Device) $88.77
- PRALUENT (Drug) $84.65
- COBALT DR MRI SURESCAN (Device) $76.80
- EMBLEM (Device) $76.77
- AZURE XT DR MRI SURESCAN (Device) $74.81
- Quadra Allure MP RF CRT Pacemkr (Device) $71.63
- RHYTHMIA (Device) $70.27
- CAMZYOS (Drug) $65.38
- JARDIANCE (Drug) $53.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Dallas
Andrew Whiteley
Internal Medicine — Payments: $1.7M
Internal Medicine $1.7M
Biff Palmer, Md, MD
Internal Medicine — Payments: $980,569
Internal Medicine $980,569
Dr. Robert Gottlieb, M.d. Ph.d, M.D. PH.D
Internal Medicine — Payments: $832,284
Internal Medicine $832,284
Dr. Ronan Kelly, Md, MD
Internal Medicine — Payments: $813,092
Internal Medicine $813,092
Dr. Gates Colbert, M.d, M.D
Internal Medicine — Payments: $801,349
Internal Medicine $801,349
Dr. Zoran Kurepa, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $743,379
Internal Medicine $743,379